UPDATE: Maxim Group Upgrades Indaptus Therapeutics (INDP) to Buy
Tweet Send to a Friend
(Updated - October 19, 2021 8:56 AM EDT)
Maxim Group analyst Jason McCarthy upgraded Indaptus Therapeutics (NASDAQ: INDP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Maxim Group analyst Jason McCarthy upgraded Indaptus Therapeutics (NASDAQ: INDP) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE